
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3145773910.1021/acsomega.7b00870ArticleCo(III)-Catalyzed C–H Activation: A Site-Selective
Conjugate Addition of Maleimide to Indole at the C-2 Position Muniraj Nachimuthu Prabhu Kandikere Ramaiah *Department of Organic Chemistry, Indian Institute of Science, Bangalore 560012, Karnataka, India* E-mail: prabhu@orgchem.iisc.ernet.in.11 08 2017 31 08 2017 2 8 4470 4479 26 06 2017 28 07 2017 Copyright © 2017 American Chemical Society2017American Chemical SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

The
cobalt(III)-catalyzed site-selective C-2 functionalization
of indole has been developed using the pyrimidinyl group as a directing
group. This reaction furnishes 3-arylated succinimide derivatives
in excellent yields in a shorter duration using an inexpensive Co
catalyst. Highly selective C-2 functionalization of indoles was achieved
in the presence of the highly reactive C-3 position. This protocol
is compatible with a variety of N-pyrimidinyl indole
and maleimide derivatives, and it can be easily scaled-up. This method
is also applicable for maleic ester and heteroarenes.

document-id-old-9ao7b00870document-id-new-14ao-2017-008703ccc-price
==== Body
Introduction
C–H
activation followed by conjugate addition to maleimides
has recently emerged as a powerful method for synthesizing 3-substituted
succinimides.1,2 The succinimide skeleton is found
in several natural products and biologically active molecules. Succinimides
are also found in some commercially available and commonly used anticonvulsants
such as phensuximide, ethosuximide, and mesuximide.3 Also, the succinimide rings are easily reduced to pyrrolidine
rings or lactams.4 Similarly, the indole
ring is found in a variety of natural products and pharmaceutically
active molecules.5 These reasons account
for the ever-continuing interest in the manipulation and derivatization
of indole scaffolds. Of late, the directing group strategy has provided
a great opportunity for the selective functionalization of indole
at the C-2, C-4, and C-7 positions. This has been achieved by using
a variety of transition metal catalysts such as Rh,6 Ru,7 Ir,8 Pd,9 and more recently, Co.10

In continuation of our own work on conjugate
addition of maleimides
with oxygen-based directing groups (amide, ketone, and carboxylic
acid),1 we decided to explore the prospect
of using nitrogen-based directing groups for the same purpose. Typically,
oxygen-based directing groups are weaker coordinating groups and behave
as hard electron donors. Therefore, most reports with oxygen-based directing groups utilize
oxophilic metals such as Ru, Rh, Pd,6−9 and Co.11,18d Nitrogen-based
directing groups have been used with several metal catalysts such
as Rh, Ru, Ir, Pd, Ni, Pt, Co, and Cu. Initially, the Co(III)-catalyzed
C–H activation reaction was reported by Kanai and Matsunaga,12 and it was then further developed by Ellman,13 Glorius,14 Chang,15 Ackermann,16 Daugulis,17 and others.18 The conjugate addition of indole (at the C-2
position) to maleimides using a Ru(II) catalyst and the benzoyl group
as a directing group was first reported by our group.1 Recently, the Co(III)-catalyzed conjugate addition of enamides
to maleimides was reported by Zhang.2h The
pyrimidinyl group has also been used as a directing group to functionalize
proximal C–H bonds with the help of various transition metals.6−10,19 In this direction, and to achieve
the current work, we used cobalt catalysts as they are easy to synthesize,
bench stable, easy to handle, and inexpensive (Scheme 1).

Scheme 1 Comparison with Previous Work
Results and Discussion
The initial screening studies
were performed using N-pyrimidinyl indole (1a) and N-ethylmaleimide
(2a) as the starting materials (Table 1). The reaction of 1a with 2a with Cp*Co(CO)I2 (5 mol %), AgSbF6 (20 mol %) as an activator, and NaOAc as an additive (20 mol %)
in DCE (2 mL) at 100 °C for 2 h furnished the product 3aa in 10% yield (entry 1). The same reaction, when performed using
trifluoroethanol (TFE) as solvent, increased the yield of 3aa to 44% (entry 2). Changing the activator from AgSbF6 to
AgBF4 or AgPF6 afforded 3aa in
20 and 19% yields, respectively (entries 3 and 4). An excellent increase
in the yield was observed (98%, entry 5) when the activator was changed
to AgOAc. The yield of the reaction was unchanged in the absence of
NaOAc (entry 6). Carrying out the reactions at 80, 50 °C, and
at ambient temperature resulted in a lower yield of 3aa (entries 7–9). Decreasing the catalyst loading to 2.5 mol
% led to the formation of 3aa in low yield (30%, entry
10). However, decreasing the amount of activator (AgOAc) to 10 mol
% still resulted in the formation of 3aa in 98% yield
(entry 11). Also, reducing the amount of 2a to 1.2 equiv
furnished 3aa in low yield (80%, entry 12). Finally,
the optimal reaction conditions were achieved by performing the reaction
of 1a (1 equiv) with 2a (1.5 equiv) using
Co(III) catalyst (5 mol %) and AgOAc (10 mol %) in TFE at 100 °C,
which furnished the product 3aa in 98% isolated yield
(entry 13). The reaction of 1a with 2a did
not proceed either in the absence of AgOAc or the Co catalyst (entries
14 and 15).

Table 1 Optimization Studiesa
entry	Ag salt (mol %)	additive (20 mol %)	solvent (2 mL)	temperature
(°C)	NMR yield
(%)b	
1	AgSbF6 (20)	NaOAc	ClCH2CH2Cl (DCE)	100	10	
2	AgSbF6 (20)	NaOAc	CF3CH2OH
(TFE)	100	44	
3	AgBF4 (20)	NaOAc	TFE	100	20	
4	AgPF6 (20)	NaOAc	TFE	100	10	
5	AgOAc (20)	NaOAc	TFE	100	98	
6	AgOAc (20)	none	TFE	100	98c	
7	AgOAc (20)	none	TFE	80	73	
8	AgOAc (20)	none	TFE	50	65	
9	AgOAc (20)	none	TFE	ambient	33	
10	AgOAc (20)	none	TFE	100	30d	
11	AgOAc (10)	none	TFE	100	98e	
12	AgOAc (10)	none	TFE	100	80f	
13	AgOAc (10)	none	TFE	100	98c,g	
14	none	none	TFE	100	nd	
15	AgOAc (10)	none	TFE	100	ndh	
a Reaction conditions: 1a (0.2 mmol), 2a (0.4 mmol), [Cp*Co(CO)I2]
(5 mol %), solvent (2 mL), for 2 h.

b 1H NMR yield (using terephthalaldehyde
as an internal standard).

c Isolated yield.

d 2.5 mol
% of Co(III) catalyst.

e 10
mol % of AgOAc.

f 1.2 equiv
of 2a.

g 1.5
equiv of 2a.

h In the absence of Co catalyst. nd
= not detected.

Having found
the optimal reaction conditions, we started exploring
the scope of the reaction (Scheme 2). Initially, the C5-substituted derivatives of indole were used as
the precursors. Accordingly, the 2-pyrimidinyl derivatives of 5-methoxyindole
and 5-bromoindole furnished the corresponding adducts 3ba and 3ca in excellent yields (93 and 95%, respectively).
5-Cyanoindole furnished 3da in 65% yield, whereas 5-nitroindole
and 5-phenylindole afforded 3ea and 3fa in
91 and 95% yields, respectively. The reactions of the 6-substituted-N-pyrimidinyl indoles with N-ethylmaleimide
were also facile. Thus, the 6-bromoindole and 6-methylester derivatives
reacted smoothly with N-ethylmaleimide (2a) and furnished the corresponding conjugate addition products 3ga and 3ha in 97 and 97% yields, respectively.
Even the sterically hindered 3-methyl substituted indole derivative
underwent a facile reaction with 2a, furnishing the product 3ia in 70% yield.

Scheme 2 Substrate Scope for Indole Derivatives,
Reaction
conditions: 1a (0.2 mmol), 2a (0.3 mmol),
[Cp*Co(CO)I2]
(5 mol %), AgOAc (10 mol %), TFE (2 mL), at 100 °C for 2 h.

Isolated yield.

After successful reactions of the 2-pyrimidinyl indole
derivatives
with N-ethylmaleimide, we continued the exploration
with a variety of maleimide derivatives (Scheme 3). Thus, the reaction of 2-pyrimidinyl indole
with N-benzylmaleimide, N-phenylmaleimide,
maleimide, N-cyclohexylmaleimide, and N-(4-acetyl)phenylmaleimide furnished the corresponding conjugate
products 4ab, 4ac, 4ad, 4ae, and 4af in excellent yields (98, 98, 80,
83, and 79%, respectively). Similarly, 5-methoxy-N-pyrimidinyl indole underwent a smooth reaction with N-benzylmaleimide, N-phenylmaleimide, and maleimide,
affording the conjugate products 4bb, 4bc, and 4bd in excellent yields (97, 98, and 93% respectively).
5-Bromo-N-pyrimidinyl indole reacted well with N-benzylmaleimide, N-phenylmaleimide, and
maleimide, furnishing the products 4cb, 4cc, and 4cd in yields of 96, 95, and 82%, respectively.
Although the reaction of dimethyl maleate with 1a proceeded
well, the reaction furnished the product 5 in low yield
(30%).

Scheme 3 Substrate Scope for Indole and Maleimide Derivatives,
Reaction
conditions: 1a (0.2 mmol), 2a (0.3 mmol),
[Cp*Co(CO)I2]
(5 mol %), AgOAc (10 mol %), TFE (2 mL), at 100 °C for 2 h.

Isolated yield.

The scope of the reaction was further extended to arenes
and heteroarenes
(Scheme 4). Thus, 2-phenylpyridine
and 2-phenylpyrimidine reacted with N-ethylmaleimide
(2a), affording the corresponding conjugated products 7aa and 7ba in moderate yields (35 and 40%, respectively).
Similarly, N-pyrmidinylpyrrole reacted with 2a, furnishing a mixture of the mono- and di-activated products 7ca and 7ca′ in 55 and 20% yields, respectively.

Scheme 4 Substrate Scope for Arenes and Heteroarenes,
Reaction conditions: 6 (0.2 mmol), 2a (0.3 mmol), [Cp*Co(CO)I2]
(5 mol %), AgOAc (10 mol %), TFE (2 mL), at 100 °C for 2 h.

Isolated yield.

After successfully synthesizing 3-arylated succinimide
derivatives,
a scaling up experiment was performed to demonstrate the efficiency
of these reactions (Scheme 5). Hence, the reaction of 1a (2.56 mmol, 500
mg) with 2a under optimal reaction conditions afforded
the corresponding product 3aa in 96% yield. Further,
the conjugated product 3aa, which contained a pyrimidyl
group, was subjected to another C–H activation reaction using
ethyl acrylate and Rh(III) catalyst.20a Interestingly, this reaction led to the formation of the corresponding
C-7 alkenylated product 8 in 74% yield (Scheme 5).

Scheme 5 Scale-Up Experiment and Synthetic Transformation
Isolated yield.

Reaction conditions: 1a (2.56 mmol), 2a (3.84 mmol), [Cp*Co(CO)I2] (5 mol %), AgOAc (10 mol %), TFE (25 mL), at 100 °C for 2
h.

To understand the selectivity for metallacycle
formation, the reaction
of 1a was performed using MeOD as a co-solvent under
optimal reaction conditions (Scheme 6). In this reaction, 16% deuteration occurred at the
C-2 position of indole, which indicated that the cobalt(III) catalyst
preferentially formed a five-membered cobaltacycle at the C-2 position
of indole. On the basis of this observation, our previous results,1e and the literature,1a,10,11d a reversible C–H activation step
is proposed in Scheme 7.

Scheme 6 Deuterium Labeling Studies
Scheme 7 Proposed Mechanism
Thus, the reaction of [Cp*Co(CO)I2] with AgOAc
generates
a cationic species of Co(III) (A) with dissociation of
CO. After the formation of the catalytically active species A, C–H metalation takes place at the proximal C-2 position
of indole with the nitrogen of the pyrimidinyl group to generate B. Following the insertion of maleimides into the cobaltacycle B, a seven-membered intermediate C is formed.
This intermediate C cannot undergo β-hydride elimination
due to the unavailability of the syn-periplanar β-hydrogen atom.
As a result, acetic acid, which is formed in the reaction, promotes
protodemetallation, thereby regenerating the active species A along with the desired product 3aa.

Conclusions
In conclusion, we have developed a novel and efficient Co(III)-catalyzed
functionalization at the C-2 position of indole with maleimides using
the pyrimidinyl group as a directing group to obtain 3-arylated succinimide
derivatives in excellent yields. This reaction proceeds quickly and
employs an inexpensive Co catalyst, compared to precious Rh and Ru
catalysts. Importantly, unlike other known catalytic systems such
as those based on Rh and Ru, this method requires a catalytic amount
of additive.

Experimental Section
General Information
All reactions were carried out
using distilled solvents. Reactions were monitored by using precoated
silica thin-layer chromatography (TLC) plates. Mass spectra were recorded
in electron ionization and electrospray ionization (ESI) (time of
flight) modes. NMR spectra were recorded at 400 MHz in CDCl3 and dimethyl sulfoxide (DMSO)-d6, and
tetramethylsilane (δ = 0.00 ppm) served as an internal standard
for 1H NMR. The corresponding residual nondeuterated solvent
signal (CDCl3, δ = 77.00 ppm and DMSO-d6, δ = 39.52 ppm) was used as the internal standard
for 13C NMR. Column chromatography was carried out with
230–400 or 100–200 mesh silica gel (Merck) and thin-layer
chromatography was carried out using SILICA GEL GF-254. Chemicals
obtained from commercial suppliers were used without further purification.
All N-pyrimidinyl indole derivatives20b and the cobalt catalyst19c were synthesized according to reported literature procedures.

Experimental Section
General Experimental Procedure
In
an 8 mL screw cap
reaction vial, N-pyrimidinyl indole (0.2 mmol), maleimide
derivative (0.3 mmol), cobalt catalyst (4.76 mg, 5 mol %), and AgOAc
(3.32 mg, 10 mol %) were added, followed by the addition of TFE (2
mL). This vial was sealed with a screw cap and placed in a preheated
metal block at 100 °C, the reaction mixture was then stirred
at the same temperature for 2 h. After completion of the reaction
(monitored by TLC), the reaction mixture was cooled to room temperature
and concentrated under vacuum. The crude products were purified on
a silica gel column using an ethyl acetate (EtOAc)/PET mixture.

Experimental Procedure for Scale-Up Reaction
In a 50
mL pressure tube, N-pyrimidinyl indole (2.56 mmol,
500 mg), N-ethylmaleimide (3.84 mmol, 480 mg), cobalt
catalyst (61 mg, 5 mol %), and AgOAc (42.5 mg, 10 mol %) were added,
followed by the addition of TFE (25 mL). This tube was sealed with
a screw cap and placed in a preheated oil bath at 100 °C, the
reaction mixture was then stirred at the same temperature for 2 h.
After completion of the reaction (monitored by TLC), the reaction
mixture was cooled to room temperature and concentrated under vacuum.
The crude products were purified on a silica gel column using an EtOAc/poly(ethylene
terephthalate) (PET) mixture.

Experimental Procedure
for Synthesis of Compound 8
In an 8 mL screw
cap reaction vial, 3aa (0.2
mmol, 64 mg), methyl acrylate (0.4 mmol, 40 mg), [Cp*RhCl2]2 (5 mol %, 6.18 mg), and Cu(OAc)2·H2O (0.2 mmol, 40 mg) were added, followed by the addition of
dimethylformamide (2 mL). This vial was sealed with a screw cap and
placed in a preheated metal block at 60 °C, the reaction mixture
was then stirred at the same temperature for 6 h. After completion
of the reaction (monitored by TLC), the reaction mixture was cooled
to room temperature and concentrated under vacuum. The crude products
were purified on a silica gel column using an EtOAc/PET mixture.

1-Ethyl-3-(1-(pyrimidin-2-yl)-1H-indol-2-yl)pyrrolidine-2,5-dione
(3aa)
Pale brown solid; yield: (63 mg, 98%);
mp: 188–190 °C; Rf (30% EtOAc/PET)
0.2; prepared as shown in general experimental procedure (a). IR (KBr,
cm–1): 1698, 1577, 1445; 1H NMR (400
MHz, CDCl3) δ (ppm): 1.24 (t, J =
7.2 Hz, 3H), 2.91 (dd, J = 18.0, 6.0 Hz, 1H), 3.12
(dd, J = 18.0, 9.2 Hz, 1H), 3.59–3.73 (m,
2H), 4.80 (dd, J = 8.4, 6.0 Hz, 1H), 6.68 (s, 1H),
7.09 (t, J = 4.8 Hz, 1H), 7.22–7.26 (m, 1H),
7.32 (d, J = 8.0 Hz, 1H), 7.56 (d, J = 8.0 Hz, 1H), 8.60–8.64 (m, 3H); 13C NMR (100
MHz, CDCl3) δ (ppm): 13.2, 33.8, 36.5, 42.3, 110.7,
115.7, 116.7, 120.3, 122.4, 124.1, 128.6, 133.8, 137.2, 157.6, 157.7,
176.1, 176.6; HRESI-MS (m/z): calcd
for C18H16N4O2 (M + Na):
343.1171, found (M + Na): 343.1174.

1-Ethyl-3-(5-methoxy-1-(pyrimidin-2-yl)-1H-indol-2-yl)pyrrolidine-2,5-dione
(3ba)
Pale brown solid; yield: (65 mg, 93%);
mp: 183–185 °C; Rf (30% EtOAc/PET)
0.2; prepared as shown in general experimental procedure (a). IR (KBr,
cm–1): 1699, 1572, 1436; 1H NMR (400
MHz, CDCl3) δ (ppm): 1.25 (t, J =
7.20 Hz, 3H), 2.90 (dd, J = 18.0, 6.0 Hz, 1H), 3.11
(dd, J = 18.0, 9.6 Hz, 1H), 3.59–3.73 (m,
2H), 3.86 (s, 3H), 4.74 (t, J = 6.4 Hz, 1H), 6.61
(s, 1H), 6.94 (dd, J = 9.2, 2.8 Hz, 1H), 7.01 (d, J = 2.4 Hz, 1H), 7.05 (t, J = 4.8 Hz, 1H),
8.56 (d, J = 9.2 Hz, 1H), 8.59 (d, J = 4.80 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ
(ppm): 13.2, 33.8, 36.5, 42.5, 55.6, 102.4, 11.4, 113.1, 116.5, 117.0,
129.5, 132.1, 134.2, 155.6, 157.5, 157.6, 176.1, 176.6; HRESI-MS (m/z): calcd for C19H18N4O3 (M + Na): 373.1277, found (M + Na): 373.1274.

3-(5-Bromo-1-(pyrimidin-2-yl)-1H-indol-2-yl)-1-ethylpyrrolidine-2,5-dione
(3ca)
Pale brown solid; yield: (79.6 mg, 95%);
mp: 199–201 °C; Rf (30% EtOAc/PET)
0.2; prepared as shown in general experimental procedure (a). IR (KBr,
cm–1): 1679, 1564, 1418; 1H NMR (400
MHz, CDCl3) δ (ppm): 1.24 (t, J =
7.2 Hz, 3H), 2.91 (dd, J = 18.0, 6.1 Hz, 1H), 3.13
(dd, J = 18.1, 9.31 Hz, 1H), 3.56–3.73 (m,
2H), 4.72–4.87 (m, 1H), 6.62 (s, 1H), 7.13 (t, J = 4.7 Hz, 1H), 7.39 (dd, J = 9.0, 1.98 Hz, 1H),
7.68 (d, J = 2.1 Hz, 1H), 8.50 (d, J = 9.1 Hz, 1H), 8.65 (d, J = 4.6 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ (ppm): 13.2, 33.9, 36.5,
42.2, 110.0, 115.7, 117.1, 117.4, 122.8, 126.8, 130.3, 135.2, 135.9,
157.4, 157.8, 175.8, 176.3; HRESI-MS (m/z): calcd for C18H15BrN4O2 (M + Na):
421.0276, found (M + Na): 421.0272.

2-(1-Ethyl-2,5-dioxopyrrolidin-3-yl)-1-(pyrimidin-2-yl)-1H-indole-5-carbonitrile (3da)
Pale
brown solid; yield: (45 mg, 65%); mp: 194–196 °C; Rf (50% EtOAc/PET) 0.3; prepared as shown in
general experimental procedure (a). IR (KBr, cm–1): 1685, 1567, 1421, 1216; 1H NMR (400 MHz, CDCl3) δ (ppm): 1.23 (t, J = 7.2 Hz, 4H), 2.92
(dd, J = 18.0, 5.8 Hz, 1H), 3.17 (dd, J = 18.1, 9.3 Hz, 1H), 3.59–3.69 (m, 2H), 4.89 (t, J = 8.4 Hz, 1H), 6.73 (s, 1H), 7.22 (t, J = 4.58 Hz, 1H), 7.53 (d, J = 8.5 Hz, 1H), 7.88
(s, 1H), 8.63 (d, J = 8.5 Hz, 1H), 8.71 (d, J = 4.9 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ (ppm): 13.2, 34.0, 36.4, 41.9, 105.6, 109.9, 116.5, 118.0,
119.9, 125.2, 126.9, 128.5, 136.7, 138.9, 157.2, 158.1, 175.6, 176.0;
HRESI-MS (m/z): calcd for C19H15N5O2 (M + Na): 368.1123,
found (M + Na): 368.1124.

1-Ethyl-3-(5-nitro-1-(pyrimidin-2-yl)-1H-indol-2-yl)pyrrolidine-2,5-dione
(3ea)
Pale yellow solid; yield: (66 mg, 91%);
mp: 239–241 °C; Rf (50% EtOAc/PET)
0.3; prepared as shown in general experimental procedure (a). IR (KBr,
cm–1): 1694, 1568, 1420, 1331; 1H NMR
(400 MHz, CDCl3) δ (ppm): 1.24 (t, J = 7.2 Hz, 3H), 2.95 (dd, J = 18.01, 6.1 Hz, 1H),
3.19 (dd, J = 18.1, 9.3 Hz, 1H), 3.58–3.72
(m, 2H), 4.91 (dd, J = 9.0, 5.9 Hz, 1H), 6.82 (s,
1H), 7.24–7.27 (m, 1H), 8.17 (dd, J = 9.3,
2.3 Hz, 1H), 8.47 (d, J = 2.1 Hz, 1H), 8.63 (d, J = 9.1 Hz, 1H), 8.73 (d, J = 4.8 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ (ppm): 13.2, 34.0,
36.3, 41.9, 110.8, 115.8, 116.7, 118.2, 119.1, 128.2, 137.5, 140.2,
143.4, 157.1, 158.2, 175.5, 175.9; HRESI-MS (m/z): calcd for C18H15N5O4 (M + Na): 388.1022, found (M + Na): 388.1021.

1-Ethyl-3-(5-phenyl-1-(pyrimidin-2-yl)-1H-indol-2-yl)pyrrolidine-2,5-dione
(3fa)
Brown solid; yield: (75.6 mg, 95%); mp:
206–208 °C; Rf (30% EtOAc/PET)
0.2; prepared as shown in general experimental procedure (a). IR (KBr,
cm–1): 1700, 1579, 1430; 1H NMR (400
MHz, DMSO-d6) δ (ppm): 1.10 (t, J = 7.3 Hz, 3H), 2.90 (dd, J = 17.4, 6.10
Hz, 1H), 3.12 (dd, J = 17.8, 9.00 Hz, 1H), 3.41–3.54
(m, 2H), 4.95–4.98 (m, 1H), 6.86 (s, 1H), 7.32–7.39
(m, 2H), 7.47 (t, J = 7.6 Hz, 2H), 7.60 (d, J = 8.5 Hz, 1H), 7.71 (d, J = 7.6 Hz, 2H),
7.88 (s, 1H), 8.54 (d, J = 8.8 Hz, 1H), 8.79 (d, J = 4.8 Hz, 2H); 13C NMR (100 MHz, DMSO-d6) δ (ppm): 12.9, 33.1, 35.9, 41.4, 110.7,
115.7, 117.9, 118.1, 122.6, 126.7, 126.8, 128.8, 128.9, 134.4, 135.4,
136.0, 140.6, 156.7, 158.5, 175.8, 176.6; HRESI-MS (m/z): calcd for C24H20N4O2 (M + Na): 419.1484, found (M + Na): 419.1483.

3-(6-Bromo-1-(pyrimidin-2-yl)-1H-indol-2-yl)-1-ethylpyrrolidine-2,5-dione
(3ga)
Pale brown solid; yield: (77.1 mg, 97%);
mp: 184–186 °C; Rf (30% EtOAc/PET)
0.2; prepared as shown in general experimental procedure (a). IR (KBr,
cm–1): 1688, 1561, 1415, 1213; 1H NMR
(400 MHz, CDCl3) δ (ppm): 1.24 (t, J = 7.2, 3H), 2.89 (dd, J = 18.0, 5.9 Hz, 1H), 3.13
(dd, J = 18.0, 9.3 Hz, 1H), 3.57–3.71 (m,
2H), 4.78–4.81 (m, 1H), 6.64 (s, 1H), 7.12 (t, J = 4.8 Hz, 1H), 7.34 (dd, J = 8.2, 1.7 Hz, 1H),
7.41 (d, J = 8.2 Hz, 1H), 8.65 (d, J = 4.8 Hz, 2H), 8.83 (d, J = 0.5 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ (ppm): 13.2, 33.9, 36.5,
42.5, 110.8, 117.2, 117.8, 118.9, 121.4, 125.8, 127.5, 134.6, 137.9,
157.4, 157.9, 175.9, 176.4; HRESI-MS (m/z): calcd for C18H15BrN4O2 (M + Na):
421.0276, found (M + Na): 421.0275.

Methyl-2-(1-ethyl-2,5-dioxopyrrolidin-3-yl)-1-(pyrimidin-2-yl)-1H-indole-6-carboxylate (3ha)
Pale
yellow solid; yield: (73.4 mg, 97%); mp: 181–183 °C; Rf (50% EtOAc/PET) 0.3; prepared as shown in
general experimental procedure (a). IR (KBr, cm–1): 1694, 1566, 1422, 1217; 1H NMR (400 MHz, CDCl3) δ (ppm): 1.23 (t, J = 7.2 Hz, 3H), 2.92
(dd, J = 18.0, 6.1 Hz, 1H), 3.15 (dd, J = 18.0, 9.4 Hz, 1H), 3.58–3.71 (m, 2H), 3.95 (s, 3H), 4.87
(dd, J = 8.7, 6.2 Hz, 1H), 6.71 (s, 1H), 7.15 (t, J = 4.7 Hz, 1H), 7.58 (d, J = 7.9 Hz, 1H),
7.92 (d, J = 7.9 Hz, 1H), 8.69 (d, J = 4.6 Hz, 2H), 9.25 (s, 1H); 13C NMR (100 MHz, CDCl3) δ (ppm): 13.2, 34.0, 36.5, 42.1, 52.0, 76.7, 77.0,
77.4, 110.2, 117.4, 117.7, 120.0, 123.6, 125.7, 132.3, 136.7, 137.3,
157.4, 158.1, 167.9, 175.8, 176.2; HRESI-MS (m/z): calcd for C20H18N4O4 (M + Na): 401.1226, found (M + Na): 401.1225.

1-Ethyl-3-(3-methyl-1-(pyrimidin-2-yl)-1H-indol-2-yl)pyrrolidine-2,5-dione
(3ia)
Pale brown solid; yield: (47 mg, 70%);
mp: 127–129 °C; Rf (30% EtOAc/PET)
0.2; prepared as shown in general experimental procedure (a). IR (KBr,
cm–1): 1700, 1571, 1440; 1H NMR (400
MHz, CDCl3) δ (ppm): 1.25 (t, J =
7.2 Hz, 3H), 2.95 (dd, J = 17.81, 6.44 Hz, 1H), 3.09
(dd, J = 17.6, 9.35 Hz, 1H), 3.57–3.74 (m,
2H), 4.62 (dd, J = 9.3, 6.5 Hz, 1H), 7.02 (t, J = 4.8 Hz, 1H), 7.25–7.27 (m, 1H), 7.31–7.35
(m, 1H), 7.54–7.56 (m, 1H), 8.56 (d, J = 4.8
Hz, 2H), 8.66 (d, J = 8.3 Hz, 1H); 13C
NMR (100 MHz, CDCl3) δ (ppm): 9.4, 13.3, 33.8, 36.2,
39.8, 113.6, 115.8, 116.2, 118.8, 122.3, 124.5, 128.6, 130.1, 136.4,
157.6, 176.5, 177.0; HRESI-MS (m/z): calcd for C19H18N4O2 (M + Na): 357.1327, found (M + Na): 357.1324.

1-Benzyl-3-(1-(pyrimidin-2-yl)-1H-indol-2-yl)pyrrolidine-2,5-dione
(4ab)
Brown solid; yield: (74.5 mg, 98%); mp:
206–208 °C; Rf (30% EtOAc/PET)
0.2; prepared as shown in general experimental procedure (a). IR (KBr,
cm–1): 1694, 1564, 1434, 1155; 1H NMR
(400 MHz, CDCl3) δ (ppm): 2.89 (dd, J = 17.8, 6.2 Hz, 1H), 3.08 (dd, J = 18.0, 9.1 Hz,
1H), 4.66 (t, J = 7.6 Hz, 1H), 4.68–4.78 (m,
2H), 6.68 (s, 1H), 6.79 (t, J = 4.7 Hz, 1H), 7.24
(t, J = 7.6 Hz, 1H), 7.29–7.34 (m, 4H), 7.51–7.55
(m, 3H), 8.04 (d, J = 4.6 Hz, 2H), 8.64 (d, J = 8.5 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ (ppm): 36.5, 42.7, 42.8, 112.0, 116.1, 116.5, 120.3, 122.6,
124.2, 128.1, 128.7, 128.8, 129.9, 133.2, 136.0, 137.3, 157.5, 157.6,
175.8, 176.5; HRESI-MS (m/z): calcd
for C23H18N4O2 (M + Na):
405.1327, found (M + Na): 405.1324.

1-Phenyl-3-(1-(pyrimidin-2-yl)-1H-indol-2-yl)pyrrolidine-2,5-dione
(4ac)
Brown solid; yield: (72 mg, 98%); mp:
245–247 °C; Rf (30% EtOAc/PET)
0.2; prepared as shown in general experimental procedure (a). IR (KBr,
cm–1): 1701, 1570, 1423, 1178; 1H NMR
(400 MHz, DMSO-d6) δ (ppm): 3.08
(dd, J = 17.7, 6.4 Hz, 1H), 3.27 (dd, J = 17.7, 9.4 Hz, 1H), 5.13 (t, J = 8.8 Hz, 1H),
6.92 (s, 1H), 7.21–7.44 (m, 6H), 7.52 (t, J = 8.0 Hz, 2H), 7.63 (d, J = 7.6 Hz, 1H), 8.53 (d, J = 8.2 Hz, 1H), 8.82 (d, J = 4.9 Hz, 2H); 13C NMR (100 MHz, DMSO-d6) δ
(ppm): 36.1, 41.8, 111.1, 115.4, 118.0, 120.3, 122.3, 123.7, 126.7,
128.2, 128.4, 129.0, 132.6, 134.3, 136.6, 156.9, 158.6, 175.2, 176.0;
HRESI-MS (m/z): calcd for C22H16N4O2 (M + Na): 391.1171,
found (M + Na): 391.1175.

3-(1-(Pyrimidin-2-yl)-1H-indol-2-yl)pyrrolidine-2,5-dione
(4ad)
White solid; yield: (46.5 mg, 80%); mp:
201–203 °C; Rf (30% EtOAc/PET)
0.2; prepared as shown in general experimental procedure (a). IR (KBr,
cm–1): 1775, 1699, 1569, 1425, 1174; 1H NMR (400 MHz, DMSO-d6) δ (ppm):
2.83 (dd, J = 17.8, 6.26 Hz, 1H), 3.05 (dd, J = 17.7, 9.4 Hz, 1H), 4.95 (dd, J = 8.8,
6.4 Hz, 1H), 6.79 (s, 1H), 7.21 (t, J = 7.3 Hz, 1H),
7.28 (t, J = 7.3 Hz, 1H), 7.41 (t, J = 4.7 Hz, 1H), 7.59 (d, J = 7.6 Hz, 1H), 8.47 (d, J = 8.2 Hz, 1H), 8.80 (d, J = 4.8 Hz, 2H),
11.24 (br. s., 1H); 13C NMR (100 MHz, DMSO-d6) δ (ppm): 37.2, 42.6, 110.1, 115.1, 117.9, 120.2,
122.1, 123.5, 128.3, 135.1, 136.5, 156.8, 158.4, 177.6, 178.3; HRESI-MS
(m/z): calcd for C16H12N4O2 (M + Na): 315.0858, found (M +
Na): 315.0856.

1-Cyclohexyl-3-(1-(pyrimidin-2-yl)-1H-indol-2-yl)pyrrolidine-2,5-dione
(4ae)
White solid; yield: (62 mg, 83%); mp:
256–258 °C; Rf (30% EtOAc/PET)
0.3; prepared as shown in general experimental procedure (a). IR (KBr,
cm–1): 1685, 1568, 1422, 1188; 1H NMR
(400 MHz, CDCl3) δ (ppm): 1.21–1.38 (m, 3H),
1.64–1.67 (m, 3H), 1.84 (d, J = 11.9 Hz, 2H),
2.16–2.25 (m, 2H), 2.89 (dd, J = 17.8, 5.6
Hz, 1H), 3.06 (dd, J = 17.8, 9.3 Hz, 1H), 4.04 (t, J = 11.9 Hz, 1H), 4.80 (br. s., 1H), 6.64 (s, 1H), 7.09
(t, J = 4.1 Hz, 1H), 7.20–7.25 (m, 1H), 7.28–7.32
(m, 1H), 7.55 (d, J = 7.6 Hz, 1H), 8.58 (d, J = 8.2 Hz, 1H), 8.67 (d, J = 4.2 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ (ppm): 25.0, 25.9,
28.9, 29.0, 36.6, 42.0, 51.8, 110.6, 115.6, 116.8, 120.3, 122.5, 124.0,
128.7, 134.8, 137.3, 157.8, 157.9, 176.2, 176.7; HRESI-MS (m/z): calcd for C22H22N4O2 (M + Na): 397.1640, found (M + Na): 397.1640.

1-(4-Acetylphenyl)-3-(1-(pyrimidin-2-yl)-1H-indol-2-yl)pyrrolidine-2,5-dione
(4af)
Pale
yellow solid; yield: (65 mg, 79%); mp: 247–249 °C; Rf (50% EtOAc/PET) 0.3; prepared as shown in
general experimental procedure (a). IR (KBr, cm–1): 1709, 1570, 1438; 1H NMR (400 MHz, DMSO-d6) δ (ppm): 2.62 (s, 3H), 3.09 (dd, J = 17.8, 6.5 Hz, 1H), 3.29 (dd, J = 17.7, 9.4 Hz,
1H), 5.14 (t, J = 8.8 Hz, 1H), 6.94 (s, 1H), 7.24
(t, J = 7.3 Hz, 1H), 7.31 (t, J =
7.6 Hz, 1H), 7.38 (t, J = 4.7 Hz, 1H), 7.53 (d, J = 8.2 Hz, 2H), 7.63 (d, J = 7.6 Hz, 1H),
8.09 (d, J = 8.2 Hz, 2H), 8.55 (d, J = 8.2 Hz, 1H), 8.80 (d, J = 4.8 Hz, 2H); 13C NMR (100 MHz, DMSO-d6) δ (ppm):
26.8, 36.0, 41.8, 111.4, 115.5, 117.8, 120.3, 122.3, 126.5, 127.0,
128.8, 134.1, 136.0, 136.5, 136.6, 156.8, 158.5, 174.8, 175.7, 197.2;
HRESI-MS (m/z): calcd for C24H18N4O3 (M + Na): 433.1277,
found (M + Na): 433.1279.

1-Benzyl-3-(5-methoxy-1-(pyrimidin-2-yl)-1H-indol-2-yl)pyrrolidine-2,5-dione (4bb)
Brown
solid; yield: (80.2 mg, 97%); mp: 201–203 °C; Rf (30% EtOAc/PET) 0.2; prepared as shown in
general experimental procedure (a). IR (KBr, cm–1): 1685, 1568, 1427, 1335, 1146; 1H NMR (400 MHz, DMSO-d6) δ (ppm): 2.87 (dd, J = 17.7, 5.8 Hz, 1H), 3.14 (dd, J = 17.7, 9.4 Hz,
1H), 3.79 (s, 3H), 4.59 (d, J = 14.3 Hz, 1H), 4.71
(d, J = 14.3 Hz, 1H), 4.97 (dd, J = 8.7, 6.2 Hz, 1H), 6.74 (s, 1H), 6.90 (dd, J =
9.1, 2.4 Hz, 1H), 7.11 (d, J = 2.1 Hz, 1H), 7.15
(t, J = 4.7 Hz, 1H), 7.34 (s, 5H), 8.39 (d, J = 4.5 Hz, 2H), 8.44 (d, J = 9.1 Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ
(ppm): 35.9, 41.7, 55.3, 102.4, 111.2, 112.6, 116.5, 117.2, 127.6,
128.3, 128.6, 129.2, 131.3, 134.8, 136.3, 155.2, 156.6, 158.1, 176.0,
176.8; HRESI-MS (m/z): calcd for
C24H20N4O3 (M + Na): 435.1433,
found (M + Na): 435.1435.

3-(5-Methoxy-1-(pyrimidin-2-yl)-1H-indol-2-yl)-1-phenylpyrrolidine-2,5-dione
(4bc)
Brown solid; yield: (78 mg, 98%); mp:
198–200 °C; Rf (30% EtOAc/PET)
0.2; prepared as shown in general experimental procedure (a). IR (KBr,
cm–1): 1715, 1438, 1214; 1H NMR (400
MHz, CDCl3) δ (ppm): 3.05 (dd, J = 18.01, 6.41 Hz, 1H), 3.26 (dd, J = 18.0, 9.4
Hz, 1H), 3.87 (s, 2H), 4.80 (t, J = 6.8 Hz, 1H),
6.70 (s, 1H), 6.96 (dd, J = 9.1, 2.4 Hz, 1H), 7.01–7.03
(m, 2H), 7.36–7.40 (m, 3H), 7.46–7.50 (m, 2H), 8.60
(d, J = 4.6 Hz, 2H), 8.64 (d, J =
9.1 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ
(ppm): 36.4, 42.9, 55.7, 102.5, 112.6, 113.3, 116.5, 117.4, 125.9,
128.3, 129.1, 129.6, 132.2, 132.3, 133.7, 155.8, 157.5, 157.8, 175.3,
175.6; HRESI-MS (m/z): calcd for
C23H18N4O3 (M + Na): 421.1277,
found (M + Na): 421.1277.

3-(5-Methoxy-1-(pyrimidin-2-yl)-1H-indol-2-yl)pyrrolidine-2,5-dione
(4bd)
Pale yellow solid; yield: (60 mg, 93%);
mp: 218–220 °C; Rf (50% EtOAc/PET)
0.2; prepared as shown in general experimental procedure (a). IR (KBr,
cm–1): 1691, 1569, 1419, 1167; 1H NMR
(400 MHz, DMSO-d6) δ (ppm): 2.81
(dd, J = 17.5, 6.2 Hz, 1H), 3.03 (dd, J = 17.7, 9.4 Hz, 1H), 3.79 (s, 3H), 4.89 (dd, J =
9.0, 6.2 Hz, 1H), 6.71 (s, 1H), 6.89 (dd, J = 9.1,
2.7 Hz, 1H), 7.11 (d, J = 2.1 Hz, 1H), 7.36 (t, J = 4.8 Hz, 1H), 8.42 (d, J = 9.1 Hz, 1H),
8.75 (d, J = 4.9 Hz, 2H), 11.23 (s, 1H); 13C NMR (100 MHz, DMSO-d6) δ (ppm):
37.2, 42.9, 55.3, 102.3, 110.4, 112.5, 116.3, 117.5, 129.2, 131.2,
135.5, 155.1, 156.7, 158.2, 177.6, 178.3; HRESI-MS (m/z): calcd for C17H14N4O3 (M + Na): 345.0964, found (M + Na): 345.0963.

1-Benzyl-3-(5-bromo-1-(pyrimidin-2-yl)-1H-indol-2-yl)pyrrolidine-2,5-dione
(4cb)
Brown solid; yield: (88 mg, 96%); mp:
154–156 °C; Rf (30% EtOAc/PET)
0.2; prepared as shown in general experimental procedure (a). IR (KBr,
cm–1): 1689, 1567, 1424, 1154; 1H NMR
(400 MHz, CDCl3) δ (ppm): 2.87 (dd, J = 17.8, 6.2 Hz, 1H), 3.06 (dd, J = 18.0, 9.4 Hz,
1H), 4.62 (t, J = 6.8 Hz 1H), 4.68–4.76 (m,
2H), 6.58 (s, 1H), 6.78 (t, J = 4.9 Hz, 1H), 7.31–7.37
(m, 4H), 7.49–7.51 (m, 2H), 7.63–7.64 (m, 1H), 8.01
(d, J = 4.2 Hz, 2H), 8.52 (d, J =
8.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ
(ppm): 36.4, 42.8, 42.8, 111.2, 115.8, 116.9, 117.8, 122.8, 126.9,
128.1, 128.8, 129.9, 130.4, 134.5, 135.9, 136.0, 157.2, 157.6, 175.6,
176.2; HRESI-MS (m/z): calcd for
C23H17BrN4O2 (M + Na):
483.0433, found (M + Na): 483.0430.

3-(5-Bromo-1-(pyrimidin-2-yl)-1H-indol-2-yl)-1-phenylpyrrolidine-2,5-dione
(4cc)
Brown solid; yield: (85 mg, 95%); mp:
239–241 °C; Rf (30% EtOAc/PET)
0.2; prepared as shown in general experimental procedure (a). IR (KBr,
cm–1): 1701, 1571, 1420, 1169; 1H NMR
(400 MHz, DMSO-d6) δ (ppm): 3.09
(dd, J = 17.7, 6.1 Hz, 1H), 3.27 (dd, J = 17.7, 9.4 Hz, 1H), 5.13–5.17 (m, 1H), 6.91 (s, 1H), 7.34
(d, J = 7.9 Hz, 2H), 7.40–7.44 (m, 3H), 7.51
(t, J = 7.6 Hz, 2H), 7.85 (s, 1H), 8.47 (d, J = 8.8 Hz, 1H), 8.83 (d, J = 4.9 Hz, 2H); 13C NMR (100 MHz, DMSO-d6) δ
(ppm): 35.9, 41.7, 110.2, 114.7, 117.3, 118.3, 122.6, 126.1, 126.6,
128.1, 128.9, 130.2, 132.5, 135.3, 135.8, 156.6, 158.7, 175.0, 175.8;
HRESI-MS (m/z): calcd for C22H15BrN4O2 (M + Na): 469.0276,
found (M + Na): 469.0276.

3-(5-Bromo-1-(pyrimidin-2-yl)-1H-indol-2-yl)pyrrolidine-2,5-dione
(4cd)
Brown solid; yield: (60 mg, 82%); mp:
272–274 °C; Rf (50% EtOAc/PET)
0.2; prepared as shown in general experimental procedure (a). IR (KBr,
cm–1): 1693, 1571, 1416, 1117; 1H NMR
(400 MHz, DMSO-d6) δ (ppm): 2.84
(dd, J = 17.7, 6.10 Hz, 1H), 3.05 (dd, J = 17.7, 9.4 Hz, 1H), 4.97 (dd, J = 9.1, 6.4 Hz,
1H), 6.78 (s, 1H), 7.39–7.45 (m, 2H), 7.81 (d, J = 1.2 Hz, 1H), 8.41 (d, J = 8.8 Hz, 1H), 8.81 (d, J = 4.9 Hz, 2H), 11.27 (s, 1H); 13C NMR (100
MHz, DMSO-d6) δ (ppm): 37.1, 42.5,
109.1, 114.5, 117.0, 118.2, 122.5, 125.9, 130.2, 135.2, 136.6, 156.5,
158.5, 177.5, 178.1; HRESI-MS (m/z): calcd for C16H11BrN4O2 (M + Na): 392.9963, found (M + Na): 392.9963.

Dimethyl
2-(1-(pyrimidin-2-yl)-1H-indol-2-yl)succinate
(5)
Yellow liquid; yield: (20.5 mg, 30%); Rf (30% EtOAc/PET) 0.5; prepared as shown in
general experimental procedure (a). IR (neat, cm–1): 1720, 1579, 1420, 1137; 1H NMR (400 MHz, CDCl3) δ (ppm): 2.97 (dd, J = 16.8, 6.0 Hz, 1H),
3.28 (dd, J = 16.4, 98.0 Hz, 1H), 3.57 (s, 3H), 3.68
(s, 3H), 5.01–5.06 (m, 1H), 6.63 (s, 1H), 7.13 (t, J = 4.8 Hz, 1H), 7.19–7.23 (m, 1H), 7.26–7.31
(m, 1H), 7.56 (d, J = 7.6 Hz, 1H), 8.47 (d, J = 8.0 Hz, 1H), 8.73 (d, J = 4.8 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ (ppm): 36.8, 42.2,
51.9, 52.2, 108.3, 114.9, 116.9, 120.4, 122.2, 123.6, 128.8, 136.6,
136.9, 157.8, 157.9, 172.1, 172.5; HRESI-MS (m/z): calcd for C16H17N3O4 (M + Na): 362.1117, found (M + Na): 362.1119.

1-Ethyl-3-(2-(pyridin-2-yl)phenyl)pyrrolidine-2,5-dione
(7aa)
Brownish semisolid; yield: (20 mg, 35%); Rf (50% EtOAc/PET) 0.3; prepared as shown in
general experimental procedure (a). IR (neat, cm–1): 1670, 1432, 1265, 1115; 1H NMR (400 MHz, CDCl3) δ (ppm): 1.16 (t, J = 7.2 Hz, 3H), 2.87
(dd, J = 18.3, 5.5 Hz, 1H), 3.15 (dd, J = 18.4, 9.6 Hz, 1H), 3.46–3.61 (m, 2H), 4.37 (dd, J = 9.6, 5.6 Hz, 1H), 7.18–7.20 (m, 1H), 7.23–7.26
(m, 1H), 7.36–7.43 (m, 2H), 7.44–7.47 (m, 1H), 7.55–7.57
(m, 1H), 7.78 (td, J = 7.6, 1.8 Hz, 1H), 8.56–8.58
(m, 1H); 13C NMR (100 MHz, CDCl3) δ (ppm):
13.0, 33.8, 38.7, 44.3, 122.1, 124.3, 127.9, 128.7, 129.2, 130.5,
135.7, 136.8, 140.3, 148.7, 159.0, 176.5, 178.3; HRESI-MS (m/z): calcd for C17H16N2O2 (M + Na): 303.1109, found (M + Na): 303.1111.

1-Ethyl-3-(2-(pyrimidin-2-yl)phenyl)pyrrolidine-2,5-dione (7ba)
Brownish semisolid; yield: (22.5 mg, 40%); Rf (50% EtOAc/PET) 0.3; prepared as shown in
general experimental procedure (a). IR (neat, cm–1): 1675, 1548, 1420, 1281, 1120; 1H NMR (400 MHz, CDCl3) δ (ppm): 1.21 (t, J = 7.2 Hz, 3H),
2.83 (dd, J = 18.1, 5.9 Hz, 1H), 3.22 (dd, J = 18.3, 9.4 Hz, 1H), 3.52–3.67 (m, 2H), 4.71 (dd, J = 9.4, 6.1 Hz, 1H), 7.17–7.26 (m, 2H), 7.42–7.47
(m, 2H), 8.16–8.18 (m, 1H), 8.75 (d, J = 4.9
Hz, 2H); 13C NMR (100 MHz, CDCl3) δ (ppm):
13.1, 33.8, 38.3, 45.7, 118.9, 128.1, 130.4, 130.6, 131.8, 136.2,
137.0, 156.8, 165.7, 176.5, 178.3; HRESI-MS (m/z): calcd for C16H15N3O2 (M + Na): 304.1062, found (M + Na): 304.1060.

1-Ethyl-3-(1-(pyrimidin-2-yl)-1H-pyrrol-2-yl)pyrrolidine-2,5-dione
(7ca)
Pale yellow solid; yield: (30 mg, 55%);
mp: 140–142 °C; Rf (50% EtOAc/PET)
0.5; prepared as shown in general experimental procedure (a). IR (KBr,
cm–1): 1683, 1573, 1434, 1405, 1124; 1H NMR (400 MHz, CDCl3) δ (ppm): 1.23 (t, J = 7.2 Hz, 3H), 2.86 (dd, J = 17.7, 6.1
Hz, 1H), 3.06 (dd, J = 17.8, 9.3 Hz, 1H), 3.59–3.72
(m, 2H), 4.56 (s, 1H), 6.24–6.29 (m, 2H), 7.03 (t, J = 4.9 Hz, 1H), 7.91 (dd, J = 3.3, 1.8
Hz, 1H), 8.49 (d, J = 4.9 Hz, 2H); 13C
NMR (100 MHz, CDCl3) δ (ppm): 13.2, 33.7, 36.6, 41.8,
110.3, 117.2, 122.5, 126.9, 156.3, 157.9, 176.5, 177.3; HRESI-MS (m/z): calcd for C14H14N4O2 (M + Na): 293.1014, found (M + Na): 293.1016.

3,3′-(1-(Pyrimidin-2-yl)-1H-pyrrole-2,5-diyl)bis(1-ethylpyrrolidine-2,5-dione)
(7ca′)
Pale greenish solid; yield: (16
mg, 20%); mp: 215–217 °C; Rf (50% EtOAc/PET) 0.1; prepared as shown in general experimental procedure
(a). IR (KBr, cm–1): 1691, 1580, 1425, 1216, 1125; 1H NMR (400 MHz, CDCl3) δ (ppm): 1.13–1.18
(m, 6H), 2.84–2.94 (m, 2H), 3.00–3.11 (m, 2H), 3.46–3.61
(m, 4H), 4.65–4.73 (m, 2H), 6.20 (d, J = 1.5
Hz, 2H), 7.15 (td, J = 4.9, 1.83 Hz, 1H), 8.56 (d, J = 4.8 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ (ppm): 13.0, 13.1, 33.7, 36.0, 36.5, 41.0, 41.1, 112.5,
118.1, 129.6, 129.9, 156.8, 157.0, 157.9, 158.0, 176.0, 176.0, 176.7,
176.8; HRESI-MS (m/z): calcd for
C20H21N5O4 (M + Na): 418.1491,
found (M + Na): 418.1490.

(E)-Ethyl
3-(2-(1-ethyl-2,5-dioxopyrrolidin-3-yl)-1-(pyrimidin-2-yl)-1H-indol-7-yl)acrylate (8)
Pale yellow
semisolid; yield–(62 mg, 74%); Rf (50% EtOAc/PET) 0.3; prepared as shown in the experimental procedure
(c). IR (neat, cm–1): 1688, 1579, 1452; 1H NMR (400 MHz, CDCl3) δ (ppm): 1.16 (t, J = 7.2 Hz, 3H), 1.23 (t, J = 7.2 Hz, 3H),
2.91 (dd, J = 18.31, 5.49 Hz, 1H), 3.05 (dd, J = 18.3, 9.46 Hz, 1H), 3.46–3.60 (m, 2H), 4.13 (q, J = 7.0 Hz, 2H), 4.72 (dd, J = 9.4, 5.5
Hz, 1H), 6.18 (d, J = 15.5 Hz, 1H), 6.62 (s, 1H),
7.17–7.22 (m, 2H), 7.30 (t, J = 4.9 Hz, 1H),
7.42 (d, J = 7.6 Hz, 1H), 7.59–7.61 (m, 1H),
8.76 (d, J = 4.9 Hz, 2H); 13C NMR (100
MHz, CDCl3) δ (ppm): 13.0, 14.3, 34.0, 36.4, 39.8,
60.1, 106.3, 117.2, 119.3, 120.9, 122.2, 122.6, 123.5, 129.6, 135.6,
136.4, 142.6, 158.1, 158.7, 166.7, 175.4, 175.7; HRESI-MS (m/z): calcd for C23H22N4O4 (M + Na): 441.1539, found (M + Na): 441.1541.

Supporting Information Available
The Supporting Information
is available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.7b00870.1H
and 13C NMR spectral data of
all compounds (PDF)



Supplementary Material
ao7b00870_si_001.pdf

 The authors
declare no competing financial interest.

Acknowledgments
This work
was supported by SERB (NO.SB/S1/OC-56/2013), New
Delhi, CSIR (No. 02(0226)15/EMR-II), New Delhi, Indian Institute of
Science, and R.L. Fine Chem. We thank Dr. A.R. Ramesha (R.L. Fine
Chem) for useful discussion. N.M. thanks UGC, New Delhi, for a fellowship.
==== Refs
References
a Lanke V. ; Bettadapur K. R. ; Prabhu K. R. 
Site-Selective Addition
of Maleimide to Indole at the C-2 Position: Ru(II)-Catalyzed C–H
Activation . Org. Lett. 
2015 , 17 , 4662 –4665 . 10.1021/acs.orglett.5b01809 .26348254  b Bettadapur K. R. ; Lanke V. ; Prabhu K. R. 
Ru (II)-Catalyzed C–H Activation:
Ketone-Directed Novel 1,4-Addition of Ortho C–H Bond to Maleimides . Org. Lett. 
2015 , 17 , 4658 –4661 . 10.1021/acs.orglett.5b01810 .26348371  c Keshri P. ; Bettadapur K. R. ; Lanke V. ; Prabhu K. R. 
Ru(II)-Catalyzed
C–H Activation: Amide-Directed 1,4-Addition of the Ortho C–H
Bond to Maleimides . J. Org. Chem. 
2016 , 81 , 6056 –6065 . 10.1021/acs.joc.6b01160 .27314834  d Bettadapur K. R. ; Lanke V. ; Prabhu K. R. 
A deciduous directing group approach
for the addition of aryl and vinyl nucleophiles to maleimides . Chem. Commun. 
2017 , 53 , 6251 –6254 . 10.1039/C7CC02392H . e Muniraj N. ; Prabhu K. R. 
Cobalt(III)-Catalyzed
C–H Activation: Azo Directed Selective 1,4-Addition of Ortho
C–H Bond to Maleimides . J. Org. Chem. 
2017 , 82 , 6913 –6921 . 10.1021/acs.joc.7b01094 .28560875 
a Miura W. ; Hirano K. ; Miura M. 
Copper-Mediated
Oxidative
Coupling of Benzamides with Maleimides via Directed C–H Cleavage . Org. Lett. 
2015 , 17 , 4034 –4037 . 10.1021/acs.orglett.5b01940 .26226391  b Han S. ; Park J. ; Kim S. ; Lee S. H. ; Sharma S. ; Mishra N. K. ; Jung Y. H. ; Kim S. 
Rhodium(III)-Catalyzed
C(sp3)–H Alkylation of 8-Methylquinolines with Maleimides . Org. Lett. 
2016 , 18 , 4666 –4669 . 10.1021/acs.orglett.6b02295 .27579822  c Sharma S. ; Han S. H. ; Oh Y. ; Mishra N. K. ; Lee S. H. ; Oh J. S. ; Kim I. S. 
Cross-Coupling of
Acrylamides and Maleimides under Rhodium Catalysis: Controlled Olefin
Migration . Org. Lett. 
2016 , 18 , 2568 –2571 . 10.1021/acs.orglett.6b00909 .27182717  d Morita T. ; Akita M. ; Satoh T. ; Kakiuchi F. ; Miura M. 
Ruthenium-Catalyzed
Cross-Coupling of Maleimides with Alkenes . Org.
Lett. 
2016 , 18 , 4598 –4601 . 10.1021/acs.orglett.6b02244 .27571229  e Sharma S. ; Han S. H. ; Jo H. ; Han S. ; Mishra N. K. ; Choi M. ; Jeong T. ; Park J. ; Kim I. S. 
Rhodium-Catalyzed Vinylic C–H Functionalization
of Enol Carbamates with Maleimides . Eur. J.
Org. Chem. 
2016 , 2016 , 3611 –3618 . 10.1002/ejoc.201600558 . f Han S. H. ; Kim S. ; De U. ; Mishra N. K. ; Park J. ; Sharma S. ; Kwak J. H. ; Han S. ; Kim H. S. ; Kim I. S. 
Synthesis of Succinimide-Containing
Chromones, Naphthoquinones, and Xanthones under Rh(III) Catalysis:
Evaluation of Anticancer Activity . J. Org. Chem. 
2016 , 81 , 12416 –12425 . 10.1021/acs.joc.6b02577 .27978756  g Zhang Z. ; Tang M. ; Han S. ; Ackermann L. ; Li J. 
Carboxylate-Enhanced Rhodium(III)-Catalyzed Aryl C–H Alkylation
with Conjugated Alkenes under Mild Conditions . J. Org. Chem. 
2017 , 82 , 664 –672 . 10.1021/acs.joc.6b02672 .27966963  h Yu W. ; Zhang W. ; Liu Y. ; Liu Z. ; Zhang Y. 
Cobalt(III)-catalyzed cross-coupling of enamides with allyl acetates/maleimides . Org. Chem. Front. 
2017 , 4 , 77 –80 . 10.1039/C6QO00479B . i Han S. H. ; Mishra N. K. ; Jo H. ; Oh Y. ; Jeon M. ; Kim S. ; Kim W. J. ; Lee J. S. ; Kim H. S. ; Kim I. S. 
One-pot Synthesis of Oxindoles through
C–H Alkylation and Intramolecular Cyclization of Azobenzenes
with Internal Olefins . Adv. Synth. Catal. 
2017 , 359 , 2396 –2401 . 10.1002/adsc.201700147 .
a Crider A. M. ; Kolczynski T. M. ; Yates K. M. 
Synthesis and anticancer
activity of nitrosourea derivatives of phensuximide . J. Med. Chem. 
1980 , 23 , 324 –326 . 10.1021/jm00177a024 .7365750  b Isaka M. ; Rugseree N. ; Maithip P. ; Kongsaeree P. ; Prabpai S. ; Thebtaranonth Y. 
Hirsutellones A–E, antimycobacterial
alkaloids from the insect pathogenic fungus Hirsutella
nivea BCC 2594 . Tetrahedron 
2005 , 61 , 5577 –5583 . 10.1016/j.tet.2005.03.099 . c Uddin J. ; Ueda K. ; Siwu E. R. O. ; Kita M. ; Uemura D. 
Cytotoxic labdane alkaloids from an ascidian Lissoclinum
sp.: Isolation, structure elucidation, and structure–activity
relationship . Bioorg. Med. Chem. 
2006 , 14 , 6954 –6961 . 10.1016/j.bmc.2006.06.043 .16854586  d Cho H. P. ; Engers D. ; Venable D. ; Niswender C. ; Lindsley C. ; Conn P. ; Emmitte K. ; Rodriguez A. 
A Novel Class
of Succinimide-Derived Negative Allosteric Modulators of Metabotropic
Glutamate Receptor Subtype 1 Provides Insight into a Disconnect in
Activity between the Rat and Human Receptors . ACS Chem. Neurosci. 
2014 , 5 , 597 –610 . 10.1021/cn5000343 .24798819 
a Hubert J. C. ; Wijnberg J. B. P. A. ; Speckamp W. N. 
NaBH4 reduction of cyclic imides . Tetrahedron 
1975 , 31 , 1437 –1441 . 10.1016/0040-4020(75)87076-1 . b Wijnberg J. B. P. A. ; Schoemaker H. E. ; Speckamp W. N. 
A regioselective reduction of gem-disubstituted succinimides . Tetrahedron 
1978 , 34 , 179 –187 . 10.1016/S0040-4020(01)93601-4 . c Katritzky A. R. ; Yao J. ; Qi M. ; Chou Y. ; Sikora D. J. ; Davis S. 
Ring Opening Reactions of Succinimides . Heterocycles 
1998 , 48 , 2677 –2691 . 10.3987/REV-98-506 . d Shemchuk L. ; Chernykh V. ; Arzumanov P. ; Levashov D. ; Shemchuk L. 
Synthesis of N-(4-oxo-3,4-dihydroquinazolin-3-yl)succinimide
and N-(4-oxoquinazolin-3-yl)succinamic acid derivatives based thereon . Russ. J. Org. Chem. 
2007 , 43 , 615 –618 . 10.1134/S1070428007040215 . e Gali H. ; Prabhu K. R. ; Karra S. R. ; Katti K. V. 
Facile
Ring-Opening Reactions of Phthalimides as a New Strategy to Synthesize
Amide-Functionalized Phosphonates, Primary Phosphines, and Bisphosphines . J. Org. Chem. 
2000 , 65 , 676 –680 . 10.1021/jo991067b .
a Kochanowska-Karamyan A. J. ; Hamann M. T. 
Marine
Indole Alkaloids:
Potential New Drug Leads for the Control of Depression and Anxiety . Chem. Rev. 
2010 , 110 , 4489 –4497 . 10.1021/cr900211p .20380420 and references therein

 b Cacchi S. ; Fabrizi G. 
Synthesis and Functionalization of Indoles Through
Palladium-Catalyzed Reactions . Chem. Rev. 
2011 , 111 , PR215 –PR283 . 10.1021/cr100403z .21557620  c Phipps R. J. ; Grimster N. P. ; Gaunt M. J. 
Cu(II)-Catalyzed Direct and Site-Selective
Arylation of Indoles Under Mild Conditions . J. Am. Chem. Soc. 
2008 , 130 , 8172 –8174 . 10.1021/ja801767s .18543910 
a Li S. ; Qin L. ; Dong L. 
Rhodium-catalyzed
C–C
coupling reactions via double C–H activation . Org. Biomol. Chem. 
2016 , 14 , 4554 –4570 . 10.1039/C6OB00209A .27099126  b Colby D. A. ; Bergman R. G. ; Ellman J. A. 
Rhodium-Catalyzed
C–C Bond Formation via Heteroatom-Directed C–H Bond
Activation . Chem. Rev. 
2010 , 110 , 624 –655 . 10.1021/cr900005n .19438203  c Ritleng V. ; Sirlin C. ; Pfeffer M. 
Ru-, Rh-, and Pd-Catalyzed C–C
Bond Formation Involving C–H Activation and Addition on Unsaturated
Substrates: Reactions and Mechanistic Aspects . Chem. Rev. 
2002 , 102 , 1731 –1770 . 10.1021/cr0104330 .11996548  d Yang L. ; Huang H. 
Transition-Metal-Catalyzed Direct
Addition of Unactivated C–H Bonds to Polar Unsaturated Bonds . Chem. Rev. 
2015 , 115 , 3468 –3517 . 10.1021/cr500610p .25749375 
a Sarkar S. D. ; Liu W. ; Kozhushkov S. I. ; Ackermann L. 
Weakly Coordinating Directing Groups for Ruthenium(II)-
Catalyzed C-H Activation . Adv. Synth. Catal. 
2014 , 356 , 1461 –1479 . 10.1002/adsc.201400110 . b Arockiam P. B. ; Bruneau C. ; Dixneuf P. H. 
Ruthenium(II)-Catalyzed C–H
Bond Activation and Functionalization . Chem.
Rev. 
2012 , 112 , 5879 –5918 . 10.1021/cr300153j .22934619 
a Shin K. ; Kim H. ; Chang S. 
Transition-Metal-Catalyzed
C–N Bond Forming Reactions Using Organic Azides as the Nitrogen
Source: A Journey for the Mild and Versatile C–H Amination . Acc. Chem. Res. 
2015 , 48 , 1040 –1052 . 10.1021/acs.accounts.5b00020 .25821998  b Kim H. ; Chang S. 
Transition-Metal-Mediated
Direct C–H Amination of Hydrocarbons with Amine Reactants:
The Most Desirable but Challenging C–N Bond-Formation Approach . ACS Catal. 
2016 , 6 , 2341 –2351 . 10.1021/acscatal.6b00293 . c Lanke V. ; Prabhu K. R. 
Iridium(III) catalyzed regioselective
amidation of indoles at the C4-position using weak coordinating groups . Chem. Commun. 
2017 , 53 , 5117 –5120 . 10.1039/C7CC00763A .
a Lyons T. W. ; Sanford M. S. 
Palladium-Catalyzed Ligand-Directed
C–H Functionalization Reactions . Chem.
Rev. 
2010 , 110 , 1147 –1169 . 10.1021/cr900184e .20078038  b Engle K. M. ; Mei T.-S. ; Wasa M. ; Yu J.-Q. 
Weak Coordination
as a Powerful Means for Developing Broadly Useful C–H Functionalization
Reactions . Acc. Chem. Res. 
2012 , 45 , 788 –502 . 10.1021/ar200185g .22166158  c Shi G. ; Zhang Y. 
Carboxylate-Directed C-H Functionalization . Adv. Synth. Catal. 
2014 , 356 , 1419 –1442 . 10.1002/adsc.201400028 .
a Moselage M. ; Li J. ; Ackermann L. 
Cobalt-Catalyzed
C–H Activation . ACS Catal. 
2016 , 6 , 498 –525 . 10.1021/acscatal.5b02344 . b Gao K. ; Yoshikai N. 
Low-Valent Cobalt Catalysis: New Opportunities for
C–H Functionalization . Acc. Chem. Res. 
2014 , 47 , 1208 –1219 . 10.1021/ar400270x .24576170  c Yoshino T. ; Matsunaga S. 
(Pentamethylcyclopentadienyl)cobalt(III)-Catalyzed
C–H Bond Functionalization: From Discovery to Unique Reactivity
and Selectivity . Adv. Synth. Catal. 
2017 , 359 , 1245 –1262 . 10.1002/adsc.201700042 . d Wang S. ; Chen S.-Y. ; Yu X.-Q. 
C–H functionalization
by high-valent Cp*Co(III) catalysis . Chem. Commun. 
2017 , 53 , 3165 –3180 . 10.1039/C6CC09651D .
a Liu X.-G. ; Zhang S.-S. ; Jiang C.-Y. ; Wu J.-Q. ; Li Q. ; Wang H. 
Cp*Co(III)-Catalyzed
Annulations of 2-Alkenylphenols with CO: Mild Access to Coumarin Derivatives . Org. Lett. 
2015 , 17 , 5404 –5407 . 10.1021/acs.orglett.5b02728 .26451846  b Wang F. ; Jin L. ; Kong L. ; Li X. 
Cobalt(III)-
and Rhodium(III)-Catalyzed C–H Amidation and Synthesis of 4-Quinolones:
C–H Activation Assisted by Weakly Coordinating and Functionalizable
Enaminone . Org. Lett. 
2017 , 19 , 1812 –1815 . 10.1021/acs.orglett.7b00583 .28358202  c Yu W. ; Zhang W. ; Liu Z. ; Zhang Y. 
Cobalt(III)-catalyzed
annulation of esters and alkynes: a facile route to indenones . Chem. Commun. 
2016 , 52 , 6837 –6840 . 10.1039/C6CC02468H . d Ikemoko H. ; Yoshino T. ; Sakata K. ; Matsunaga S. ; Kanai M. 
Pyrroloindolone Synthesis via a Cp*CoIII-Catalyzed
Redox-Neutral Directed C–H Alkenylation/Annulation Sequence . J. Am. Chem. Soc. 
2014 , 136 , 5424 –5431 . 10.1021/ja5008432 .24650237 
a Yoshino T. ; Ikemoto H. ; Matsunaga S. ; Kanai M. 
A Cationic High-Valent
Cp*CoIII Complex for the Catalytic Generation
of Nucleophilic Organometallic Species: Directed C-H Bond Activation . Angew. Chem., Int. Ed. 
2013 , 52 , 2207 –2211 . 10.1002/anie.201209226 . b Sun B. ; Yoshino T. ; Kanai M. ; Matsunaga S. 
Cp*CoIII Catalyzed Site-Selective C-H Activation of
Unsymmetrical O-Acyl Oximes: Synthesis of Multisubstituted Isoquinolines
from Terminal and Internal Alkynes . Angew. Chem.,
Int. Ed. 
2015 , 54 , 12968 –12972 . 10.1002/anie.201507744 . c Suzuki Y. ; Sun B. ; Sakata K. ; Matsunaga S. ; Kanai M. 
Dehydrative Direct C-H Allylation with Allylic Alcohols under [Cp*CoIII]
Catalysis . Angew. Chem., Int. Ed. 
2015 , 54 , 9944 –9947 . 10.1002/anie.201503704 .
a Hummel J. R. ; Ellman J. A. 
Cobalt(III)-Catalyzed
Synthesis of Indazoles and Furans by C–H Bond Functionalization/Addition/Cyclization
Cascades . J. Am. Chem. Soc. 
2015 , 137 , 490 –498 . 10.1021/ja5116452 .25494296  b Boerth J. A. ; Hummel J. R. ; Ellman J. A. 
Highly Stereoselective Cobalt(III)-Catalyzed
Three-Component C–H Bond Addition Cascade . Angew. Chem., Int. Ed. 
2016 , 55 , 12650 –12654 . 10.1002/anie.201603831 .
a Lerchen A. ; Vasqueź-Cespedes S. ; Glorius F́ 
Cobalt(III)-Catalyzed
Redox-Neutral Synthesis of Unprotected
Indoles Featuring an N–N Bond Cleavage . Angew. Chem., Int. Ed. 
2016 , 55 , 3208 –3211 . 10.1002/anie.201510705 . b Lu Q. ; Vasquez-Cé spedes S. ; Gensch T. ; Glorius F́ 
Control over Organometallic Intermediate
Enables Cp*Co(III) Catalyzed Switchable Cyclization to Quinolines
and Indoles . ACS Catal. 
2016 , 6 , 2352 –2356 . 10.1021/acscatal.6b00367 .
a Park J. ; Chang S. 
Comparative Catalytic
Activity of Group 9 [Cp*MIII] Complexes: Cobalt-Catalyzed C-H Amidation
of Arenes with Dioxazolones as Amidating Reagents . Angew. Chem., Int. Ed. 
2015 , 54 , 14103 –14107 . 10.1002/anie.201505820 . b Patel P. ; Chang S. 
Cobalt(III)-Catalyzed
C–H Amidation of Arenes using Acetoxycarbamates as Convenient
Amino Sources under Mild Conditions . ACS Catal. 
2015 , 5 , 853 –858 . 10.1021/cs501860b .
a Li J. ; Ackermann L. 
Cobalt(III)-Catalyzed
Aryl and Alkenyl C-H Aminocarbonylation with Isocyanates and Acyl
Azides . Angew. Chem., Int. Ed. 
2015 , 54 , 8551 –8554 . 10.1002/anie.201501926 . b Li J. ; Ackermann L. 
Cobalt-Catalyzed C-H Cyanation of Arenes and Heteroarenes . Angew. Chem., Int. Ed. 
2015 , 54 , 3635 –3638 . 10.1002/anie.201409247 . c Ma W. ; Ackermann L. 
Cobalt(II)-Catalyzed
Oxidative C–H Alkenylations: Regio- and Site-Selective Access
to Isoindolin-1-one . ACS Catal. 
2015 , 5 , 2822 –2825 . 10.1021/acscatal.5b00322 .
a Grigorjeva L. ; Daugulis O. 
Cobalt-Catalyzed, Aminoquinoline-Directed
C(sp2)-H Bond Alkenylation by Alkynes . Angew.
Chem., Int. Ed. 
2014 , 53 , 10209 –10212 . 10.1002/anie.201404579 . b Nguyen T. T. ; Grigorjeva L. ; Daugulis O. 
Cobalt-Catalyzed, Aminoquinoline-Directed
Functionalization of Phosphinic Amide sp2 C–H Bonds . ACS Catal. 
2016 , 6 , 551 –555 . 10.1021/acscatal.5b02391 .27525171 
a Zhang Z.-Z. ; Liu B. ; Xu J.-W. ; Yan S.-Y. ; Shi B.-F. 
Indole Synthesis via Cobalt(III)-Catalyzed
Oxidative Coupling of N-Arylureas and Internal Alkynes . Org. Lett. 
2016 , 18 , 1776 –1779 . 10.1021/acs.orglett.6b00494 .27023432  b Wang F. ; Wang H. ; Wang Q. ; Yu S. ; Li X. 
Co(III)-Catalyzed Synthesis of Quinazolines via C–H Activation
of N-Sulfinylimines and Benzimidates . Org. Lett. 
2016 , 18 , 1306 –1309 . 10.1021/acs.orglett.6b00227 .26954622  c Liu X.-G. ; Zhang S.-S. ; Jiang C-Y. ; Wu J.-Q. ; Li Q. ; Wang H. 
Cp*Co(III)-Catalyzed Annulations of 2-Alkenylphenols
with CO: Mild Access to Coumarin Derivatives . Org. Lett. 
2015 , 17 , 5404 –5407 . 10.1021/acs.orglett.5b02728 .26451846  d Sen M. ; Emayavaramban B. ; Barsu N. ; Premkumar J. R. ; Sundararaju B. 
Cp*Co(III)-Catalyzed C(sp3)–H Bond Activation:
A Highly Stereoselective and Regioselective Alkenylation of 8-Methylquinoline
with Alkynes . ACS Catal. 
2016 , 6 , 2792 –2796 . 10.1021/acscatal.6b00612 . e Kalsi D. ; Laskar R. A. ; Barsu N. ; Premkumar J. R. ; Sundararaju B. 
C-8-Selective Allylation of Quinoline: A Case Study
of β-Hydride vs β-Hydroxy Elimination . Org. Lett. 
2016 , 18 , 4198 –4201 . 10.1021/acs.orglett.6b01845 .27533734  f Hübner S. ; de Vries J. G. ; Farina V. 
Why Does Industry
Not Use Immobilized Transition Metal Complexes as Catalysts . Adv. Synth. Catal. 
2016 , 358 , 3 –25 . 10.1002/adsc.201500846 .
a Mei R. ; Loup J. ; Ackermann L. 
Oxazolinyl-Assisted
C–H Amidation by Cobalt(III) Catalysis . ACS Catal. 
2016 , 6 , 793 –797 . 10.1021/acscatal.5b02661 . b Neufeldt S. R. ; Jimeńez-Oses G. ; Huckins J. R. ; Thiel O. R. ; Houḱ K. N. 
Pyridine N-Oxide vs Pyridine Substrates for Rh(III)-Catalyzed
Oxidative C–H Bond Functionalization . J. Am. Chem. Soc. 
2015 , 137 , 9843 –9854 . 10.1021/jacs.5b03535 .26197041  c Sun B. ; Yoshino T. ; Matsunaga S. ; Kanai M. 
Air-Stable Carbonyl(pentamethylcyclopentadienyl)cobalt Diiodide Complex
as a Precursor for Cationic (Pentamethylcyclopentadienyl)cobalt(III)
Catalysis: Application for Directed C-2 Selective C-H Amidation of
Indoles . Adv. Synth. Catal. 
2014 , 356 , 1491 –1495 . 10.1002/adsc.201301110 . d Li J. ; Zhang Z. ; Ma W. ; Tang M. ; Wang D. ; Zou L-H. 
Mild Cobalt(III)-Catalyzed C–H Hydroarylation of Conjugated
C=C/C=O Bonds . Adv. Synth. Catal. 
2017 , 359 , 1717 –1724 . 10.1002/adsc.201700097 . e Gensch T. ; Vásquez-Céspedes S. ; Yu D-G. ; Glorius F. 
Cobalt(III)-Catalyzed Directed C–H
Allylation . Org. Lett. 
2015 , 17 , 3714 –3717 . 10.1021/acs.orglett.5b01701 .26172276  f Kong L. ; Zhou X. ; Li X. 
Cobalt(III)-Catalyzed
Regio- and Stereoselective α-Fluoroalkenylation of Arenes with
gem-Difluorostyrenes . Org. Lett. 
2016 , 18 , 6320 –6323 . 10.1021/acs.orglett.6b03203 .27978627  g Kong L. ; Yu S. ; Tang G. ; Wang H. ; Zhou X. ; Li X. 
Cobalt(III)-Catalyzed C–C
Coupling of Arenes with 7-Oxabenzonorbornadiene and 2-Vinyloxirane
via C–H Activation . Org. Lett. 
2016 , 18 , 3802 –3805 . 10.1021/acs.orglett.6b01806 .27391142  h While
this manuscript was under preparation, a similar work appeared in Organic letterrs: Zhang Z. ; Han S. ; Tang M. ; Ackermann L. ; Li J. 
C–H Alkylations
of (Hetero)Arenes by Maleimides and Maleate Esters through Cobalt(III)
Catalysis . Org. Lett. 
2017 , 19 , 3315 –3318 . 10.1021/acs.orglett.7b01480 .28590740 
a Shi J. ; Yan Y. ; Li Q. ; Xu H. E. ; Yi W. 
Rhodium(III)-catalyzed C2-selective
carbenoid functionalization and subsequent C7-alkenylation of indoles . Chem. Commun. 
2014 , 50 , 6483 –6486 . 10.1039/c4cc01593b . b Ackermann L. ; Lygin A. V. 
Ruthenium-Catalyzed
Direct C–H Bond Arylations of Heteroarenes . Org. Lett. 
2011 , 13 , 3332 –3335 . 10.1021/ol2010648 .21644545

